Quantcast

Latest Stem cells Stories

2014-06-06 23:05:52

Patients with a particularly stubborn type of breast cancer could potentially benefit by supplementing radiation treatments with a generic, low-cost medication commonly prescribed to treat high cholesterol, according to a new study released today in Stem Cells Translational Medicine. Durham, NC (PRWEB) June 06, 2014 Patients with a particularly stubborn type of breast cancer could potentially benefit by supplementing radiation treatments with a generic, low-cost medication commonly...

2014-06-06 12:24:21

Dr. Michael Zahalsky Presents Results During American Urological Association Medical Conference CORAL SPRINGS, Fla., June 6, 2014 /PRNewswire-iReach/ -- Dr. Michael Zahalsky, a prominent South Florida Urologist, was chosen to give a podium presentation at the 2014 Annual Meeting of the American Urological Association, May 16-21 in Orlando to discuss the results of his research on the use of stem cells to treat erectile dysfunction. Over a six-month period, Dr. Zahalsky studied the...

2014-06-05 12:31:31

FARMINGTON, Conn., June 5, 2014 /PRNewswire/ -- ImStem Biotechnology, Inc. (ImStem) announced today it has successfully treated an animal model of multiple sclerosis (MS) using human embryonic stem cells (hESC) derived mesenchymal stem cells (MSCs), called hES-MSCs. Photo - http://photos.prnewswire.com/prnh/20140605/94816Photo - http://photos.prnewswire.com/prnh/20140605/94808 MS is a chronic neuroinflammatory disease with no cure. Most current MS therapies offer only palliative...

Scientists Successfully Transplant And Grow Stem Cells In Pigs
2014-06-05 03:38:48

Nathan Hurst, University of Missouri One of the biggest challenges for medical researchers studying the effectiveness of stem cell therapies is that transplants or grafts of cells are often rejected by the hosts. This rejection can render experiments useless, making research into potentially life-saving treatments a long and difficult process. Now, researchers at the University of Missouri have shown that a new line of genetically modified pigs will host transplanted cells without the...

2014-06-05 08:28:12

EYSINS, Switzerland, June 5, 2014 /PRNewswire/ -- In line with its mission of market innovator, Biosafe is proud to announce the launch of the SepaMax multiprocessing device, on the occasion of the International Cord Blood Symposium in San Francisco. (Logo: http://photos.prnewswire.com/prnh/20140407/679480 ) SepaMax is designed for high throughput cell processing. Based on Biosafe's industry-leading Sepax technology, it offers six processing modules in a...

2014-06-04 23:07:48

OTTR Chronic Care Solutions Inc. ™ has successfully supported its first customer, Barnes-Jewish Hospital of Washington University School of Medicine in St. Louis, Missouri, in the submission, and retrieval, of transplant data using the AGNIS application and framework in a production environment. Omaha, NE (PRWEB) June 04, 2014 OTTR Chronic Care Solutions Inc. ™ has successfully supported its first customer, Barnes-Jewish Hospital of Washington University School of Medicine in St....

2014-06-04 23:06:47

Insception Lifebank, Canada's largest cord blood program, now offers expecting parents the option to bank a section of the actual umbilical cord tissue, in addition to banking cord blood. Toronto, Canada (PRWEB) June 04, 2014 Insception Lifebank, Canada's largest cord blood program, now offers expecting parents the option to bank a section of the actual umbilical cord tissue, in addition to banking cord blood. "With exciting developments in stem cell research, scientists...

2014-06-04 12:29:10

Surveyed U.S. Payers Will Accept High Yearly Costs for Effective Novel Treatments, According to Findings from Decision Resources Group BURLINGTON, Mass., June 4, 2014 /PRNewswire/ -- Decision Resources Group finds that surveyed U.S. retinal specialists are highly willing to prescribe key emerging therapies for the treatment of geographic atrophy (GA), the dry form of advanced age-related macular degeneration (AMD). In particular, clinicians expect to prescribe Roche/Genentech's lampalizumab...

2014-06-03 23:02:06

On June 3, at the 7th Annual Massachusetts Life Sciences Innovation Day, Dr. James L. Sherley, Director of The Adult Stem Cell Technology Center, LLC presented a new technology developed to identify drug candidates that are toxic to adult stem cells. This first technology of its kind meets a long-standing unmet need of the pharmaceutical industry, with potential to save billions of dollars in drug development costs each year while accelerating the arrival of new effective, and safe, drugs...

2014-06-03 12:38:22

LONDON, June 3, 2014 /PRNewswire/ -- Reportbuyer.com has added a new market research report:Biobanking for Medicine: Technology, Industry and Market 2014-2024http://www.reportbuyer.com/pharma_healthcare/biotechnology/biobanking_medicine_technology_market.html Report DetailsBiobanks - how to find business trends, R&D, and revenue forecastsWhat does the future hold for medical biobanks? Now you get technological and commercial predictions from 2014. Stay ahead, then, for data,...


Word of the Day
mallemaroking
  • Nautical, the visiting and carousing of sailors in the Greenland ships.
This word is apparently from a confusion of two similar Dutch words: 'mallemerok,' a foolish woman, and 'mallemok,' a name for some persons among the crew of a whaling vessel.